Squarepoint Ops LLC Bei Gene, Ltd. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Squarepoint Ops LLC holds 72,709 shares of BGNE stock, worth $13.4 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

72,709

Previous 72,055 0.91%

Holding current value

$13.4 Million

Previous $10.3 Million 58.78%

% of portfolio

0.03%

Previous 0.02%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$143.93 - $224.51 $94,130 - $146,829	654 Added 0.91%	72,709 $16.3 Million
Q2 2024 Aug 14, 2024	BUY	$129.52 - $174.32 $225,753 - $303,839	1,743 Added 2.48%	72,055 $10.3 Million
Q1 2024 May 15, 2024	BUY	$141.8 - $181.47 $6.99 Million - $8.95 Million	49,320 Added 234.95%	70,312 $11 Million
Q4 2023 Feb 14, 2024	BUY	$158.67 - $201.58 $1.99 Million - $2.53 Million	12,552 Added 148.72%	20,992 $3.79 Million
Q2 2023 Aug 14, 2023	BUY	$178.3 - $266.78 $819,110 - $1.23 Million	4,594 Added 119.45%	8,440 $1.5 Million
Q1 2023 May 15, 2023	BUY	$215.53 - $274.5 $828,928 - $1.06 Million	3,846 New	3,846 $828,000
Q3 2022 Nov 14, 2022	SELL	$131.8 - $202.24 $229,463 - $352,099	-1,741 Reduced 42.04%	2,400 $324,000
Q2 2022 Aug 15, 2022	BUY	$121.11 - $216.05 $233,863 - $417,192	1,931 Added 87.38%	4,141 $670,000
Q1 2022 May 16, 2022	BUY	$146.52 - $269.56 $1,904 - $3,504	13 Added 0.59%	2,210 $417,000
Q4 2021 Feb 14, 2022	BUY	$248.56 - $389.34 $66,614 - $104,343	268 Added 13.89%	2,197 $595,000
Q3 2021 Nov 15, 2021	SELL	$249.6 - $403.14 $1.33 Million - $2.15 Million	-5,342 Reduced 73.47%	1,929 $700,000
Q2 2021 Aug 16, 2021	BUY	$292.75 - $367.01 $2.13 Million - $2.67 Million	7,271 New	7,271 $2.5 Million
Q4 2020 Feb 16, 2021	SELL	$221.31 - $316.61 $433,988 - $620,872	-1,961 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$189.18 - $286.44 $370,981 - $561,708	1,961 New	1,961 $562,000
Q1 2020 May 15, 2020	SELL	$121.84 - $173.19 $298,508 - $424,315	-2,450 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$115.78 - $208.34 $283,661 - $510,433	2,450 New	2,450 $406,000
Q3 2019 Nov 14, 2019	SELL	$120.61 - $148.29 $504,029 - $619,703	-4,179 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$113.99 - $146.86 $476,364 - $613,727	4,179 New	4,179 $518,000
Q4 2018 Feb 14, 2019	SELL	$107.01 - $175.15 $177,315 - $290,223	-1,657 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$152.62 - $189.66 $252,891 - $314,266	1,657 New	1,657 $285,000
Q4 2017 Feb 14, 2018	SELL	$79.6 - $114.73 $249,705 - $359,908	-3,137 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$66.19 - $103.46 $207,638 - $324,554	3,137	3,137 $325,000

Others Institutions Holding BGNE

# of Institutions

252

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $19.2B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Bei Gene, Ltd. Transaction History